RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma

Hepatocellular carcinoma (HCC), one of the most common and lethal cancers worldwide, has a high recurrence rate with current treatment modalities. Identifying biomarkers for early diagnosis and discovering new sufficient molecular targets for the development of targeted therapies are urgently needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Jia, Wei-Dong, Hu, Bing, Pan, Yue-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432270/
https://www.ncbi.nlm.nih.gov/pubmed/28460436
http://dx.doi.org/10.18632/oncotarget.15507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432270/
https://www.ncbi.nlm.nih.gov/pubmed/28460436
http://dx.doi.org/10.18632/oncotarget.15507

Ejemplares similares